Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives
Monica Iorfida, Manuelita Mazza, Elisabetta Munzone Division of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, ItalyCorrespondence: Elisabetta MunzoneDivision of Medical Senology, European Institute of Oncology, IRCCS, via Ripamonti 435, Milano 20141, ItalyTel +39 02 57489970...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e694915222e5428886b3e22c2c99c156 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|